{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:16:08Z","timestamp":1778134568495,"version":"3.51.4"},"reference-count":213,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Antibiot."],"abstract":"<jats:p>\n                    The disease tuberculosis, caused by\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    , is one of the leading causes of global human mortality. The rise of multidrug and extensively drug-resistant strains of the pathogen and the limited efficacy of the BCG vaccine is one of the major concerns worldwide. Conventional chemotherapy for tuberculosis is often very long and has several side effects. These factors lead to an urgent need for alternative, non-toxic therapeutic strategies with minimal side effects. Antimycobacterial peptides (AMPs), are a class of natural compounds that have shown a broad spectrum of anti-mycobacterial activity with a low propensity for the development of anti-mycobacterial resistance. This review summarizes the current antimycobacterial peptides, highlighting their structural features, physicochemical determinants, and their mechanism of action. Some of the key peptides have been critically discussed with respect to their membrane targeting mechanism. The role of structural modifications, such as disulfide bonding, cyclization, hydrophobicity tuning, and post-translational modifications, in enhancing antimycobacterial efficacy and stability is also examined. Consequently, the broad mechanism of action of these peptides and their role in the development of anti-tuberculosis drugs have been emphasized. This article combines mechanistic and structural insights to show how antimycobacterial peptides could become new anti-TB drugs. It also provides a guide for developing and improving peptide therapies for tuberculosis.\n                  <\/jats:p>","DOI":"10.3389\/frabi.2026.1769369","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:44:31Z","timestamp":1778132671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimycobacterial peptides as natural therapeutics for tuberculosis: mechanisms and structural features"],"prefix":"10.3389","volume":"5","author":[{"given":"Pulak","family":"Pritam","sequence":"first","affiliation":[{"name":"Environmental Science Laboratory, School of Applied Sciences, Kalinga Institute of Industrial Technology, Deemed to be University","place":["Bhubaneswar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreelipta","family":"Das","sequence":"additional","affiliation":[{"name":"Environmental Science Laboratory, School of Applied Sciences, Kalinga Institute of Industrial Technology, Deemed to be University","place":["Bhubaneswar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep Kumar","family":"Behera","sequence":"additional","affiliation":[{"name":"Environmental Science Laboratory, School of Applied Sciences, Kalinga Institute of Industrial Technology, Deemed to be University","place":["Bhubaneswar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monali","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Environmental Science Laboratory, School of Applied Sciences, Kalinga Institute of Industrial Technology, Deemed to be University","place":["Bhubaneswar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lopamudra","family":"Subudhi","sequence":"additional","affiliation":[{"name":"Centre for Biotechnology, Siksha O Anusandhan (Deemed to be University)","place":["Bhubaneswar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibani","family":"Mohapatra","sequence":"additional","affiliation":[{"name":"Centre for Biotechnology, Siksha O Anusandhan (Deemed to be University)","place":["Bhubaneswar, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok Kumar","family":"Panda","sequence":"additional","affiliation":[{"name":"Environmental Science Laboratory, School of Applied Sciences, Kalinga Institute of Industrial Technology, Deemed to be University","place":["Bhubaneswar, India"]},{"name":"Centre for Water Research and Climate Change, Kalinga Institute of Industrial Technology Deemed to Be University","place":["Bhubaneswar, Odisha, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/jac\/dku570","article-title":"Natural antimicrobial peptides against Mycobacterium tuberculosis","volume":"70","author":"Abedinzadeh","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.colsurfb.2016.07.054","article-title":"Comparative analysis of new peptide conjugates of antitubercular drug candidates\u2014Model membrane and in vitro studies","volume":"147","author":"\u00c1brah\u00e1m","year":"2016","journal-title":"Colloids Surf. B. Biointerfaces"},{"key":"B3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bcp.2016.09.018","article-title":"Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria","volume":"133","author":"Ageitos","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftae005","article-title":"Interplay between gut microbiota and the master iron regulator, hepcidin, in the pathogenesis of liver fibrosis","volume":"82","author":"Ahmadi Badi","year":"2024","journal-title":"Pathog. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1128\/aac.00628-11","article-title":"Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin","volume":"55","author":"Akbergenov","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.phrs.2017.10.011","article-title":"Antimicrobial peptides as an alternative to anti-tuberculosis drugs","volume":"128","author":"AlMatar","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1073\/pnas.0700036104","article-title":"Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy","volume":"104","author":"Alonso","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.biocel.2018.09.007","article-title":"Human \u03b2-defensin 1 update: Potential clinical applications of the restless warrior","volume":"104","author":"\u00c1lvarez","year":"2018","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s12602-022-10018-6","article-title":"Antimicrobial peptides as Immunomodulators and Antimycobacterial agents to combat Mycobacterium tuberculosis: a critical review","author":"Anbarasu","year":"2023"},{"key":"B10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1042\/bj3440845","article-title":"Identification of an anti-mycobacterial domain in NK-lysin and granulysin","volume":"344","author":"Andreu","year":"1999","journal-title":"Biochem. J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D","article-title":"Animal antimicrobial peptides: An overview","volume":"47","author":"Andreu","year":"1998","journal-title":"Pept. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.23917\/pharmacon.v22i2.12071","article-title":"Comparing the hematological effects of BPaL\/BPaLM regimens to those of standard regimens in the treatment of drug-resistant tuberculosis: a narrative review","volume":"22","author":"Apgar","year":"2025","journal-title":"Pharmacon: Jurnal Farmasi Indonesia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01499","article-title":"Host antimicrobial peptides: The promise of new treatment strategies against tuberculosis","volume":"8","author":"Arranz-Trull\u00e9n","year":"2017","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jbiosc.2009.01.003","article-title":"Lantibiotics: diverse activities and unique modes of action","volume":"107","author":"Asaduzzaman","year":"2009","journal-title":"J. Biosci. Bioeng."},{"key":"B15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12992-024-01046-8","article-title":"AMR and sustainable development goals: at a crossroads","volume":"20","author":"Aslam","year":"2024","journal-title":"Globalization Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ph15080975","article-title":"Intestinal absorption study: Challenges and absorption enhancement strategies in improving oral drug delivery","volume":"15","author":"Azman","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijmyco.2015.07.002","article-title":"Interaction of antimicrobial peptide with mycolyl transferase in Mycobacterium tuberculosis","volume":"5","author":"Banerjee","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1021\/acs.orglett.5b03292","article-title":"Total synthesis of cyclomarin A, a marine cycloheptapeptide with anti-tuberculosis and anti-malaria activity","volume":"18","author":"Barbie","year":"2016","journal-title":"Org. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12602-022-09929-1","article-title":"Designing anti-microbial peptides against major \u03b2-lactamase enzymes in clinically important gram-negative bacterial pathogens: an in-silico study","volume":"14","author":"Basu","year":"2022","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/joim.12767","article-title":"Daily adjunctive therapy with vitamin <scp>D<\/scp>3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia","volume":"284","author":"Bekele","year":"2018","journal-title":"J. Internal Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047745","article-title":"Mechanisms of peptide-induced pore formation in lipid bilayers investigated by oriented 31P solid-state NMR spectroscopy","volume":"18","author":"Bertelsen","year":"2012"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.974101","article-title":"How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery","volume":"12","author":"Bhagwat","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202503964","article-title":"Redefining therapies for drug\u2010resistant tuberculosis: Synergistic effects of antimicrobial peptides, nanotechnology, and computational design","volume":"15","author":"Carnero Canales","year":"2026","journal-title":"Adv. Healthcare Mater"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioteChadv.2020.107603","article-title":"Nanostructured antimicrobial peptides: The last push towards clinics","volume":"44","author":"Carratal\u00e1","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijantimicag.2010.03.029","article-title":"Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria","volume":"36","author":"Carroll","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e3929","DOI":"10.1093\/cid\/ciaa621","article-title":"Aminoglycosides and capreomycin in the treatment of multidrug-resistant tuberculosis: individual patient data meta-analysis of 12\u2013030 patients from 25 countries, 2009\u20132016","volume":"73","author":"Cegielski","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ni727","article-title":"Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung","volume":"2","author":"Chen","year":"2001","journal-title":"Nat. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1128\/aac.00925-06","article-title":"Role of peptide hydrophobicity in the mechanism of action of \u03b1-helical antimicrobial peptides","volume":"51","author":"Chen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1074\/jbc.m413406200","article-title":"Rational design of \u03b1-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11551","DOI":"10.1073\/pnas.0505359102","article-title":"Mass of the postsynaptic density and enumeration of three key molecules","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/20\/46\/465706","article-title":"Nanolayer biofilm coated on magnetic nanoparticles by using a dielectric barrier dischargeglow plasma fluidized bed for immobilizing an antimicrobial peptide","volume":"20","author":"Chen","year":"2009","journal-title":"Nanotechnology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02204-18","article-title":"Rufomycin targets ClpC1 proteolysis in Mycobacterium tuberculosis and M. abscessus","volume":"63","author":"Choules","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.str.2005.03.013","article-title":"Structural dissection of ATP turnover in the prototypical GHL ATPase TopoVI","volume":"13","author":"Corbett","year":"2005","journal-title":"Structure"},{"key":"B35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pep.2013.02.007","article-title":"Bacterial expression and antibiotic activities of recombinant variants of human \u03b2-defensins on pathogenic bacteria and M. tuberculosis","volume":"89","author":"Corrales-Garcia","year":"2013","journal-title":"Protein Expression Purif."},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins\u2014a viable alternative to antibiotics","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1080\/03639045.2019.1608231","article-title":"Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment","volume":"45","author":"Cunha","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1016\/j.febslet.2015.11.002","article-title":"Role of arginine and lysine in the antimicrobial mechanism of histone\u2010derived antimicrobial peptides","volume":"589","author":"Cutrona","year":"2015","journal-title":"FEBS Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/s0014-5793(01)02648-5","article-title":"Optimization of the antimicrobial activity of magainin peptides by modification of charge","volume":"501","author":"Dathe","year":"2001","journal-title":"FEBS Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0005-2736(99)00201-1","article-title":"Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells","volume":"1462","author":"Dathe","year":"1999","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1613241","article-title":"Antimycobacterial activity of the plectasin derivative NZ2114","volume":"16","author":"Davids","year":"2025","journal-title":"Front. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9060337","article-title":"Metal\u2013peptide complexes as promising antibiotics to fight emerging drug resistance: New perspectives in tuberculosis","volume":"9","author":"Di Natale","year":"2020","journal-title":"J. A."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/biom10040652","article-title":"Antimicrobial and antibiofilm peptides","volume":"10","author":"Di Somma","year":"2020","journal-title":"J. B."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s44368-024-00007-y","article-title":"Nano-strategies used for combatting the scourge of tuberculosis infections","volume":"1","author":"Fang","year":"2024","journal-title":"Discover Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41579-024-01025-1","article-title":"Drug-resistant tuberculosis: a persistent global health concern","volume":"22","author":"Farhat","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antibiotics11121785","article-title":"In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis","volume":"25","author":"Fattorini","year":"2004","journal-title":"Peptides"},{"key":"B47","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1189\/jlb.1104688","article-title":"Prodefensins are matrix proteins of specific granules in human neutrophils","volume":"78","author":"Faurschou","year":"2005","journal-title":"J. Leukocyte Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jmb.2007.05.016","article-title":"Folding amphipathic helices into membranes: Amphiphilicity trumps hydrophobicity","volume":"370","author":"Fern\u00e1ndez-Vidal","year":"2007","journal-title":"J. Mol. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"9922","DOI":"10.1021\/bi301426j","article-title":"Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes","volume":"51","author":"Foss","year":"2012","journal-title":"Biochemistry"},{"key":"B50","first-page":"1027","article-title":"The potential of human neutrophil peptides in tuberculosis therapy","volume":"7","author":"Fu","year":"2003","journal-title":"Int. J. Tuberc Lung Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nri1180","article-title":"Defensins: antimicrobial peptides of innate immunity","volume":"3","author":"Ganz","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/aac.04054-14","article-title":"The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1021\/ol5026603","article-title":"Discovery and characterization of the tuberculosis drug lead ecumicin","volume":"16","author":"Gao","year":"2014","journal-title":"Org. Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1128\/aac.01164-06","article-title":"Inhaled large porous particles of capreomycin for treatment of tuberculosis in a Guinea pig model","volume":"51","author":"Garcia-Contreras","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0008-8749(91)90136-y","article-title":"Human neutrophil peptide defensins induce single strand DNA breaks in target cells","volume":"138","author":"Gera","year":"1991","journal-title":"Cell. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/s11535-007-0010-5","article-title":"Antimicrobial peptides: an overview of a promising class of therapeutics","volume":"2","author":"Giuliani","year":"2007","journal-title":"Open Life Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)81895-4","article-title":"Human \u03b2-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis","volume":"88","author":"Goldman","year":"1997","journal-title":"Cell."},{"key":"B58","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.humimm.2011.03.027","article-title":"Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus","volume":"72","author":"Gonzalez-Curiel","year":"2011","journal-title":"Hum. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1128\/aac.00464-12","article-title":"Mouse model for efficacy testing of antituberculosis agents via intrapulmonary delivery","volume":"56","author":"Gonzalez-Juarrero","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010007","article-title":"Safety and effectiveness of BPaL-based regimens to treat multidrug-resistant TB: First experience of an Italian tuberculosis referral hospital","volume":"14","author":"Gualano","year":"2024","journal-title":"Antibiotics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061223","article-title":"Preclinical studies of granulysin-based anti-MUC1-Tn immunotoxins as a new antitumoral treatment","volume":"10","author":"Guerrero-Ochoa","year":"2022","journal-title":"Biomedicines"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00203-025-04393-1","article-title":"Unveiling the potential of antimicrobial peptides to combat Mycobacterium tuberculosis","volume":"207","author":"Gupta","year":"2025","journal-title":"Arch. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/path.4878","article-title":"Bacterial subversion of <scp>cAMP<\/scp> signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis","volume":"242","author":"Gupta","year":"2017","journal-title":"J. Pathol."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00224","article-title":"Beyond research: a primer for considerations on using viral metagenomics in the field and clinic","volume":"6","author":"Hall","year":"2015","journal-title":"Front. Microbiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/bip.22250","article-title":"Peptide design for antimicrobial and immunomodulatory applications","volume":"100","author":"Haney","year":"2013","journal-title":"Pept. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.fsi.2016.11.029","article-title":"A TFPI-1 peptide that induces degradation of bacterial nucleic acids, and inhibits bacterial and viral infection in half-smooth tongue sole, Cynoglossus semilaevis","volume":"60","author":"He","year":"2017","journal-title":"Fish. Shellfish Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1007\/s11947-025-03755-3","article-title":"Different strategies for the biosynthesis of bioactive peptide using bioengineering technology in Pichia pastoris: A review","volume":"18","author":"Hong","year":"2025","journal-title":"Food Bioprocess Technol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.1021\/ja056780z","article-title":"Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a lasso structure","volume":"128","author":"Iwatsuki","year":"2006","journal-title":"J. Am. Chem. Soc"},{"key":"B69","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s12010-012-9834-1","article-title":"Detection and confirmation of alkaloids in leaves of Justicia adhatoda and bioinformatics approach to elicit its anti-tuberculosis activity","volume":"168","author":"Jha","year":"2012","journal-title":"Appl. Biochem. Biotechnol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/bip.20911","article-title":"Effects of net charge and the number of positively charged residues on the biological activity of amphipathic \u03b1\u2010helical cationic antimicrobial peptides","volume":"90","author":"Jiang","year":"2008","journal-title":"Pept. Sci."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1027394","article-title":"The evolving biology of Mycobacterium tuberculosis drug resistance","volume":"12","author":"Jones","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.bbamem.2015.01.007","article-title":"Helical cationic antimicrobial peptide length and its impact on membrane disruption","volume":"1848","author":"Juba","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1086\/424463","article-title":"Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy","volume":"190","author":"Kalita","year":"2004","journal-title":"J. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1242\/jcs.106815","article-title":"Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species","volume":"125","author":"Kalo","year":"2012","journal-title":"J. Cell Sci."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/md19080446","article-title":"Recent developments on the synthesis and bioactivity of ilamycins\/rufomycins and cyclomarins, marine cyclopeptides that demonstrate anti-malaria and anti-tuberculosis activity","volume":"19","author":"Kazmaier","year":"2021","journal-title":"Mar. Drugs"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1021\/ol502472c","article-title":"Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces","volume":"16","author":"Khalil","year":"2014","journal-title":"Org. Lett."},{"key":"B77","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2147\/ijn.s54171","article-title":"Nanoparticles in relation to peptide and protein aggregation","volume":"9","author":"Khan","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"B78","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1002\/chem.201901640","article-title":"Synthesis of new cyclomarin derivatives and their biological evaluation towards Mycobacterium tuberculosis and Plasmodium falciparum","volume":"25","author":"Kiefer","year":"2019","journal-title":"Chem. Eur. J."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00171","article-title":"Host-directed therapeutic strategies for tuberculosis","volume":"4","author":"Kolloli","year":"2017","journal-title":"Front. Med."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128292","article-title":"Advancing roles of nitric oxide in tuberculosis: Promising targets for novel anti-TB therapeutics","volume":"300","author":"Kong","year":"2025","journal-title":"Microbiol. Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09657","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00144","article-title":"The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs","volume":"5","author":"Kuroda","year":"2015","journal-title":"Front. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s10753-012-9463-4","article-title":"Bacterial cell wall constituents induce hepcidin expression in macrophages through MyD88 signaling","volume":"35","author":"Layoun","year":"2012","journal-title":"Inflammation"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02340-16","article-title":"Intracellular targeting mechanisms by antimicrobial peptides","volume":"61","author":"Le","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B85","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.iy.11.040193.000541","article-title":"Defensins: antimicrobial and cytotoxic peptides of mammalian cells","volume":"11","author":"Lehrer","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00073","article-title":"Membrane active antimicrobial peptides: translating mechanistic insights to design","volume":"11","author":"Li","year":"2017","journal-title":"Front. Neurosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1128\/aac.00428-09","article-title":"Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids","volume":"53","author":"Li","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B88","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1016\/j.bmcl.2011.09.031","article-title":"Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives","volume":"21","author":"Li","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B89","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.peptides.2014.04.014","article-title":"Characterization and bioactivity of hepcidin-2 in zebrafish: Dependence of antibacterial activity upon disulfide bridges","volume":"57","author":"Lin","year":"2014","journal-title":"Peptides"},{"key":"B90","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1128\/iai.73.10.6332-6339.2005","article-title":"Conserved structure and function in the granulysin and NK-lysin peptide family","volume":"73","author":"Linde","year":"2005","journal-title":"Infect. Immun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12602-020-09686-z","article-title":"Analogs of the cathelicidin-derived antimicrobial peptide PMAP-23 exhibit improved stability and antibacterial activity","volume":"13","author":"Liu","year":"2021","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.70078","article-title":"A comprehensive review of recombinant technology in the food industry: Exploring expression systems, application, and future challenges","volume":"24","author":"Liu","year":"2025","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.bbamem.2009.05.012","article-title":"Biological activity and structural aspects of PGLa interaction with membrane mimetic systems","volume":"1788","author":"Lohner","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"B94","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1021\/jp067127g","article-title":"Study of the interaction of human defensins with cell membrane models: relationships between structure and biological activity","volume":"111","author":"Lourenzoni","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020170","article-title":"Recent advances in nanotechnology-based strategies for bone tuberculosis management","volume":"17","author":"Luo","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s12602-020-09648-5","article-title":"Design and synthesis of lipopolysaccharide-binding antimicrobial peptides based on truncated rabbit and human CAP18 peptides and evaluation of their action mechanism","volume":"12","author":"Madanchi","year":"2020","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/s1473-3099(20)30327-3","article-title":"The value of antimicrobial peptides in the age of resistance","volume":"20","author":"Magana","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: opportunities and challenges","volume":"40","author":"Mahlapuu","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/femsre\/fuz016","article-title":"Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles\u2019 heel for the TB-causing pathogen","volume":"43","author":"Maitra","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/liv.13977","article-title":"Human beta\u2010defensin\u20101 is a highly predictive marker of mortality in patients with acute\u2010on\u2010chronic liver failure","volume":"39","author":"Mani","year":"2019","journal-title":"Liver Int."},{"key":"B102","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2217\/17460913.2.5.513","article-title":"The expanding role of lipid II as a target for lantibiotics","volume":"2","author":"Martin","year":"2007","journal-title":"Future Microbiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.4049\/jimmunol.178.11.7190","article-title":"IFN-\u03b3- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37","volume":"178","author":"Martineau","year":"2007","journal-title":"J. Immunol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097928","article-title":"Small RNA MTS1338 configures a stress resistance signature in Mycobacterium tuberculosis","volume":"24","author":"Martini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.1021\/bi00019a033","article-title":"Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore","volume":"34","author":"Matsuzaki","year":"1995","journal-title":"Biochemistry"},{"key":"B106","doi-asserted-by":"publisher","first-page":"11361","DOI":"10.1021\/bi960016v","article-title":"An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation","volume":"35","author":"Matsuzaki","year":"1996","journal-title":"Biochemistry"},{"key":"B107","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1086\/518655","article-title":"Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome","volume":"196","author":"McIlleron","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1742-4658.2006.05166.x","article-title":"Mycobacterium tuberculosis H37Rv ESAT\u20106\u2013CFP\u201010 complex formation confers thermodynamic and biochemical stability","volume":"273","author":"Meher","year":"2006","journal-title":"FEBS J."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10989-022-10435-9","article-title":"Role of antimicrobial peptides in treatment and prevention of Mycobacterium tuberculosis: a review","volume":"28","author":"Mehta","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.peptides.2008.05.024","article-title":"Role of antimicrobial peptides in host defense against mycobacterial infections","volume":"29","author":"M\u00e9ndez-Samperio","year":"2008","journal-title":"Peptides"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bbamem.2010.04.004","article-title":"Antimicrobial peptides in toroidal and cylindrical pores","volume":"1798","author":"Mihajlovic","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138340","article-title":"Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial","volume":"10","author":"Mily","year":"2015","journal-title":"One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2021.117340","article-title":"Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: a molecular docking and molecular dynamics simulation study","volume":"341","author":"Miryala","year":"2021","journal-title":"J. Mol. Liq."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2022.108146","article-title":"Datasets comprising the quality validations of simulated protein-ligand complexes and SYBYL docking scores of bioactive natural compounds as inhibitors of Mycobacterium tuberculosis protein-targets","volume":"42","author":"Miryala","year":"2022","journal-title":"Data Brief"},{"key":"B115","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/iai.64.3.926-932.1996","article-title":"In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis","volume":"64","author":"Miyakawa","year":"1996","journal-title":"Infect. Immun."},{"key":"B116","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/ph8030366","article-title":"Peptides and peptidomimetics for antimicrobial drug design","volume":"8","author":"Mojsoska","year":"2015","journal-title":"Pharmaceuticals"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.phytochem.2011.07.014","article-title":"Pitipeptolides C\u2013F, antimycobacterial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula from Guam","volume":"72","author":"Montaser","year":"2011","journal-title":"Phytochemistry"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27984","article-title":"Unraveling resistance mechanisms in combination therapy: a comprehensive review of recent advances and future directions","volume":"10","author":"Morales-Dur\u00e1n","year":"2024","journal-title":"Heliyon"},{"key":"B119","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12602-019-09546-5","article-title":"Metal binding antimicrobial peptides in nanoparticle bio-functionalization: new heights in drug delivery and therapy","volume":"12","author":"Moulahoum","year":"2020","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029367","article-title":"Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescence","volume":"6","author":"Mueller","year":"2011","journal-title":"One"},{"key":"B121","doi-asserted-by":"publisher","first-page":"161","DOI":"10.11400\/kekkaku1923.39.5_161","article-title":"Effectiveness of capreomycin against experimental tuberculosis of mice and Guinea pigs","volume":"39","author":"Nakamura","year":"1964","journal-title":"Kekkaku (Tuberculosis)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28062744","article-title":"MSF enhances human antimicrobial peptide \u03b2-defensin (HBD2 and HBD3) expression and attenuates inflammation via the NF-\u03ba B and P38 signaling pathways","volume":"28","author":"Nguyen","year":"2023","journal-title":"Molecules"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1172\/jci0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"J. Clin. Invest."},{"key":"B124","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/exd.13314","article-title":"Friends or foes? Host defense (antimicrobial) peptides and proteins in human skin diseases","volume":"26","author":"Niyonsaba","year":"2017","journal-title":"Exp. Dermatol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"30883","DOI":"10.1074\/jbc.m113.493767","article-title":"Structural basis of mycobacterial inhibition by Cyclomarin A","volume":"288","author":"Noble","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1128\/aac.02542-14","article-title":"Synergistic effects of antimicrobial peptides and antibiotics against Clostridium difficile","volume":"58","author":"Nuding","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B127","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5455\/JMID.2025.v15.i3.4","article-title":"Next-generation antimicrobial peptides: emerging therapeutic strategies against Mycobacterium tuberculosis","volume":"15","author":"Obaid","year":"2025","journal-title":"J. Microbiol. Infect. Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/s1473-3099(16)30139-6","article-title":"Zoonotic tuberculosis in human beings caused by Mycobacterium bovis\u2014a call for action","volume":"17","author":"Olea-Popelka","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3390\/ph14040323","article-title":"Antimicrobial peptides as potential anti-tubercular leads: a concise review","volume":"14","author":"Oliveira","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B130","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1111\/febs.16369","article-title":"Secretory proteins of Mycobacterium tuberculosis and their roles in modulation of host immune responses: focus on therapeutic targets","volume":"289","author":"Pal","year":"2022","journal-title":"FEBS J."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010075","article-title":"In vitro, in vivo and in silico assessment of the antimicrobial and immunomodulatory effects of a water buffalo cathelicidin (WBCATH) in experimental pulmonary tuberculosis","volume":"12","author":"Palacios","year":"2022","journal-title":"Antibiotics"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2539192","article-title":"Endogenous hepcidin plays an essential role in Mycobacterium tuberculosis Rv1876 antigen-induced antimicrobial activity in macrophages","volume":"14","author":"Park","year":"2025","journal-title":"Emerging Microbes Infect."},{"key":"B133","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/bip.20679","article-title":"Structure\u2010activity relationship of HP (2\u201320) analog peptide: enhanced antimicrobial activity by N\u2010terminal random coil region deletion","volume":"88","author":"Park","year":"2007","journal-title":"Pept. Sci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"8245","DOI":"10.1073\/pnas.150518097","article-title":"Structure\u2013activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II","volume":"97","author":"Park","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1383098","article-title":"The role of ESAT-6 in tuberculosis immunopathology","volume":"15","author":"Passos","year":"2024","journal-title":"Front. Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/07388551.2011.594423","article-title":"Antimicrobial peptides: key components of the innate immune system","volume":"32","author":"Pasupuleti","year":"2011","journal-title":"Crit. Rev. Biotechnol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.2174\/138161207782110381","article-title":"Human defensins: synthesis and structural properties","volume":"13","author":"Pazgier","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"B138","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1099\/jmm.0.000912","article-title":"In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates","volume":"68","author":"Portell-Buj","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.bmcl.2010.04.100","article-title":"Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp. are active against dormant mycobacteria","volume":"20","author":"Pruksakorn","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/j.1462-5822.2007.01039.x","article-title":"Lysosomal ubiquitin and the demise of Mycobacterium tuberculosis","volume":"9","author":"Purdy","year":"2007","journal-title":"Cell. Microbiol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/675391","article-title":"Antimicrobial peptides: versatile biological properties","volume":"2013","author":"Pushpanathan","year":"2013","journal-title":"Int. J. Pept."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s12602-022-10018-6","article-title":"Antimicrobial peptides as immunomodulators and antimycobacterial agents to combat Mycobacterium tuberculosis: a critical review","volume":"15","author":"R","year":"2022","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"B143","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.2147\/ijn.s207527","article-title":"Antifungal effects of indolicidin-conjugated gold nanoparticles against fluconazole-resistant strains of Candida albicans isolated from patients with burn infection","author":"Rahimi","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1039\/d1tb02617h","article-title":"Antimicrobial peptide-based materials: opportunities and challenges","volume":"10","author":"Rai","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftac032","article-title":"Mycobacterial response to an acidic environment: protective mechanisms","volume":"80","author":"Rai","year":"2022","journal-title":"Pathog. Dis."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83755-3","article-title":"A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy","volume":"11","author":"Rao","year":"2021","journal-title":"Sci. Rep."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147188","article-title":"Essentiality assessment of cysteinyl and lysyl-tRNA synthetases of Mycobacterium smegmatis","volume":"11","author":"Ravishankar","year":"2016","journal-title":"One"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/s0140-6736(19)30024-8","article-title":"Building a tuberculosis-free world: The Lancet Commission on tuberculosis","volume":"393","author":"Reid","year":"2019","journal-title":"Lancet"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2012.24.2.126","article-title":"Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease","volume":"24","author":"Reinholz","year":"2012","journal-title":"Ann. Dermatol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3203-9","article-title":"Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy","volume":"18","author":"Rekha","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"B151","doi-asserted-by":"publisher","first-page":"11578","DOI":"10.1039\/d1cc03793e","article-title":"Advances on chemically modified antimicrobial peptides for generating peptide antibiotics","volume":"57","author":"Rezende","year":"2021","journal-title":"Chem. Commun."},{"key":"B152","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cmi.2020.07.004","article-title":"Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens","volume":"26","author":"Rivi\u00e8re","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030289","article-title":"Protegrin-1 and analogues against acinetobacter baumannii: A narrative review","volume":"18","author":"Rizzetto","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/ph18101440","article-title":"Peptide-based strategies against Mycobacterium tuberculosis covering immunomodulation, vaccines, synergistic therapy, and nanodelivery","volume":"18","author":"Roque-Borda","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.bbamem.2008.10.020","article-title":"Antimicrobial peptide mimics for improved therapeutic properties","volume":"1788","author":"Rotem","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13050439","article-title":"AMPs as host-directed immunomodulatory agents against skin infections caused by opportunistic bacterial pathogens","volume":"13","author":"Saha","year":"2024","journal-title":"Antibiotics"},{"key":"B158","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/acsinfecdis.4c00806","article-title":"Decoding the role of antimicrobial peptides in the fight against Mycobacterium tuberculosis","volume":"11","author":"Saini","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32003","article-title":"Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistance","volume":"10","author":"Sarangi","year":"2024","journal-title":"Heliyon"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00500-21","article-title":"Surface-shaving proteomics of Mycobacterium marinum identifies biofilm subtype-specific changes affecting virulence, tolerance, and persistence","volume":"6","author":"Savijoki","year":"2021","journal-title":"mSystems"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni732","article-title":"Dermcidin: a novel human antibiotic secret peptide by sweat tassels","volume":"2","author":"Schittek","year":"2001","journal-title":"Nat. Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni732","article-title":"Dermcidin: a novel human antibiotic peptide secreted by sweat glands","volume":"2","author":"Schittek","year":"2001","journal-title":"Nat. Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1002\/ange.201101740","article-title":"The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease","volume":"50","author":"Schmitt","year":"2011","journal-title":"Angewandte Chemie (Int. Ed. English)"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22452\/jummec.vol17no1.1","article-title":"Net charge, hydrophobicity and specific amino acids contribute to the activity of antimicrobial peptides","volume":"17","author":"Sd","year":"2014","journal-title":"J. Health Trans. Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1083\/jcb.118.4.929","article-title":"Enteric defensins: antibiotic peptide components of intestinal host defense","volume":"118","author":"Selsted","year":"1992","journal-title":"J. Cell Biol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ni1206","article-title":"Mammalian defensins in the antimicrobial immune response","volume":"6","author":"Selsted","year":"2005","journal-title":"Nat. Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.bbamem.2008.06.007","article-title":"Toroidal pores formed by antimicrobial peptides show significant disorder","volume":"1778","author":"Sengupta","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA) - Biomembr."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s11095-023-03488-y","article-title":"Co-delivery of D-LAK antimicrobial peptide and capreomycin as inhaled powder formulation to combat drug-resistant tuberculosis","volume":"40","author":"Shao","year":"2023","journal-title":"Pharm. Res."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123960","article-title":"Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis","volume":"654","author":"Shao","year":"2024","journal-title":"Int. J. Pharm."},{"key":"B170","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s002840010263","article-title":"DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H 37 Ra","volume":"43","author":"Sharma","year":"2001","journal-title":"Curr. Microbiol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1002\/chem.201404650","article-title":"Cell penetrating synthetic antimicrobial peptides (SAMPs) exhibiting potent and selective killing of Mycobacterium by targeting its DNA","volume":"21","author":"Sharma","year":"2015","journal-title":"Chem. Eur. J."},{"key":"B172","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijpharm.2018.12.076","article-title":"Mycobactericidal activity of some micro-encapsulated synthetic host defense peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis","volume":"558","author":"Sharma","year":"2019","journal-title":"Int. J. Pharm."},{"key":"B173","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s002030050719","article-title":"Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra","volume":"171","author":"Sharma","year":"1999","journal-title":"Arch. Microbiol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1034\/j.1399-3003.2000.16a20.x","article-title":"Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study","volume":"16","author":"Sharma","year":"2000","journal-title":"Eur. Respir. J."},{"key":"B175","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1128\/aac.45.2.639-640.2001","article-title":"Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis","volume":"45","author":"Sharma","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/bf01927571","article-title":"The chemical structure of capreomycin","volume":"32","author":"Shiba","year":"1976","journal-title":"Experientia"},{"key":"B177","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10989-018-9677-x","article-title":"Antimicrobial peptide cathelicidin-BF inhibits platelet aggregation by blocking protease-activated receptor 4","volume":"25","author":"Shu","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"key":"B178","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.bioteChadv.2016.05.007","article-title":"Antimicrobial peptides as novel anti-tuberculosis therapeutics","volume":"34","author":"Silva","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"B179","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jconrel.2016.05.064","article-title":"Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment","volume":"235","author":"Silva","year":"2016","journal-title":"J. Controlled Release"},{"key":"B180","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2217\/fmb-2017-0135","article-title":"Cell envelope lipids in the pathophysiology of Mycobacterium tuberculosis","volume":"13","author":"Singh","year":"2018","journal-title":"Future Microbiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1128\/aac.47.2.494-500.2003","article-title":"NP-1, a rabbit \u03b1-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2","volume":"47","author":"Sinha","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B182","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1073\/pnas.1214739110","article-title":"Crystal structure and functional mechanism of a human antimicrobial membrane channel","author":"Song","year":"2013"},{"key":"B183","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1189\/jlb.0407216","article-title":"Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis","volume":"82","author":"Sow","year":"2007","journal-title":"J. Leukocyte Biol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.tube.2011.03.003","article-title":"Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin","volume":"91","author":"Sow","year":"2011","journal-title":"Tuberculosis"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.tet.2004.11.053","article-title":"Ziziphine N, O, P and Q, new antiplasmodial cyclopeptide alkaloids from Ziziphus oenoplia var. brunoniana","volume":"61","author":"Suksamrarn","year":"2005","journal-title":"Tetrahedron"},{"key":"B186","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1002\/anie.201609079","article-title":"Nonribosomal peptide synthesis\u2014principles and prospects","volume":"56","author":"S\u00fcssmuth","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1093\/femsmc\/xtag003","article-title":"Enhanced antibacterial activity of antimicrobial peptide\u2014antibiotic combinations against multidrug-resistant bacteria","volume":"7","author":"Talha","year":"2026","journal-title":"FEMS Microbes"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102202","article-title":"Antibacterial peptide CyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1\u2013ClpP1P2 protease","volume":"298","author":"Taylor","year":"2022","journal-title":"J. Biol. Chem."},{"key":"B189","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000369711","article-title":"Anti-mycobacterial peptides: from human to phage","volume":"35","author":"Teng","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"B190","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tube.2018.10.008","article-title":"A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis","volume":"113","author":"Tenland","year":"2018","journal-title":"Tuberculosis"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.micinf.2006.02.030","article-title":"Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype","volume":"8","author":"Toro","year":"2006","journal-title":"Microbes Infect."},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016968","article-title":"Connecting peptide physicochemical and antimicrobial properties by a rational prediction model","volume":"6","author":"Torrent","year":"2011","journal-title":"One"},{"key":"B193","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1016\/j.jmb.2018.12.015","article-title":"Peptide design principles for antimicrobial applications","volume":"431","author":"Torres","year":"2019","journal-title":"J. Mol. Biol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1128\/iai.00936-15","article-title":"LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages","volume":"83","author":"Torres-Juarez","year":"2015","journal-title":"Infect. Immun."},{"key":"B195","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/s0006-3495(00)76455-1","article-title":"Polar angle as a determinant of amphipathic \u03b1-helix-lipid interactions: A model peptide study","volume":"79","author":"Uematsu","year":"2000","journal-title":"Biophys. J."},{"key":"B196","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/aac.00749-08","article-title":"New drugs against tuberculosis: Problems, progress, and evaluation of agents in clinical development","volume":"53","author":"van den Boogaard","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B197","doi-asserted-by":"publisher","first-page":"34120","DOI":"10.1074\/jbc.m112.359067","article-title":"Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic \u03b1-helical peptides","volume":"287","author":"Vermeer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B198","doi-asserted-by":"publisher","first-page":"D1154","DOI":"10.1093\/nar\/gkt1157","article-title":"CAMP: Collection of sequences and structures of antimicrobial peptides","volume":"42","author":"Waghu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B199","doi-asserted-by":"publisher","first-page":"12869","DOI":"10.1021\/bi971398n","article-title":"Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides","volume":"36","author":"Wieprecht","year":"1997","journal-title":"Biochemistry"},{"key":"B200","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/acsinfecdis.8b00276","article-title":"High-resolution structure of ClpC1-rufomycin and ligand binding studies provide a framework to design and optimize anti-tuberculosis leads","volume":"5","author":"Wolf","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"B201","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","year":"2014"},{"key":"B202","volume-title":"Roadmap for zoonotic tuberculosis","year":"2017"},{"key":"B203","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.peptides.2011.01.010","article-title":"Effect of proline position on the antimicrobial mechanism of buforin II","volume":"32","author":"Xie","year":"2011","journal-title":"Peptides"},{"key":"B204","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/s0924-8579(03)00110-9","article-title":"In vitro activities of small peptides from snake venom against clinical isolates of drug-resistant Mycobacterium tuberculosis","volume":"22","author":"Xie","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B205","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-97-6270-5_19","article-title":"Diversifying expression platforms for biopharmaceuticals and industrial enzymes","volume-title":"Industrial microbiology and biotechnology","author":"Yadav","year":"2024"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mco2.353","article-title":"Mycobacterium tuberculosis: Pathogenesis and therapeutic targets","volume":"4","author":"Yang","year":"2023","journal-title":"MedComm"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1002\/psc.3213","article-title":"A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity","volume":"25","author":"Yathursan","year":"2019","journal-title":"J. Pept. Sci."},{"key":"B208","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1074\/jbc.m111.303602","article-title":"Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions","volume":"287","author":"Yin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B209","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30071529","article-title":"Advances in antimicrobial peptides: mechanisms, design innovations, and biomedical potential","volume":"30","author":"Zhang","year":"2025","journal-title":"Molecules"},{"key":"B211","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1359-6446(05)03626-3","article-title":"New drug candidates and therapeutic targets for tuberculosis therapy","volume":"11","author":"Zhang","year":"2006","journal-title":"Drug Discov. Today"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066557","article-title":"LAMP: a database linking antimicrobial peptides","volume":"8","author":"Zhao","year":"2013","journal-title":"J.P.O."},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00128","article-title":"Application of antimicrobial peptides of the innate immune system in combination with conventional antibiotics\u2014a novel way to combat antibiotic resistance","volume":"9","author":"Zharkova","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Antibiotics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2026.1769369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:44:37Z","timestamp":1778132677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2026.1769369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":213,"alternative-id":["10.3389\/frabi.2026.1769369"],"URL":"https:\/\/doi.org\/10.3389\/frabi.2026.1769369","relation":{},"ISSN":["2813-2467"],"issn-type":[{"value":"2813-2467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"1769369"}}